CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.
暂无分享,去创建一个
J. Drijfhout | A. Sewell | A. Skowera | M. Peakman | T. Tree | C. Dayan | B. Roep | F. Ossendorp | G. Huang | C. Rackham | A. Zaremba | W. Unger | Min Zhao | S. Arif | R. Varela-Calviño | R. Ellis | Jennifer S. Allen | C. Van-Krinks
[1] Å. Sjöholm,et al. A busy cell—Endoplasmic reticulum stress in the pancreatic β-cell , 2007, Molecular and Cellular Endocrinology.
[2] R. A. Bailey,et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.
[3] M. Peakman,et al. Translational Mini‐Review Series on Type 1 Diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes , 2007, Clinical and experimental immunology.
[4] M. Peakman,et al. Translational Mini‐Review Series on Type 1 Diabetes: Immune‐based therapeutic approaches for type 1 diabetes , 2007, Clinical and experimental immunology.
[5] Tatiana Tatusova,et al. NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..
[6] Å. Sjöholm,et al. A busy cell--endoplasmic reticulum stress in the pancreatic beta-cell. , 2007, Molecular and cellular endocrinology.
[7] Q. Ouyang,et al. Identification of Novel HLA-A*0201–Restricted Epitopes in Recent-Onset Type 1 Diabetic Subjects and Antibody-Positive Relatives , 2006, Diabetes.
[8] M. Peakman,et al. HLA Class I Epitope Discovery in Type 1 Diabetes , 2006, Annals of the New York Academy of Sciences.
[9] Peter M. Jones,et al. Identification of insulin signaling elements in human beta-cells: autocrine regulation of insulin gene expression. , 2006, Diabetes.
[10] R. Offringa,et al. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants , 2006, Nature Medicine.
[11] Pau Serra,et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice , 2006, Nature Immunology.
[12] J. Drijfhout,et al. Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes , 2005 .
[13] Nils Welsh,et al. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. , 2005, Diabetes.
[14] S. Wessely,et al. Analysis of Anthrax and Plague Biowarfare Vaccine Interactions with Human Monocyte-Derived Dendritic Cells1 , 2005, The Journal of Immunology.
[15] J. Drijfhout,et al. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] N. Heaton,et al. Insulin-producing cells derived from human pancreatic non-endocrine cell cultures reverse streptozotocin-induced hyperglycaemia in mice , 2005, Diabetologia.
[17] J. Foley,et al. Alpha cell function in health and disease: influence of glucagon-like peptide-1 , 2005, Diabetologia.
[18] C. Boitard,et al. Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] P. van Endert,et al. Identification of naturally processed HLA-A2--restricted proinsulin epitopes by reverse immunology. , 2005, Diabetes.
[20] G. Eisenbarth,et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice , 2005, Nature.
[21] R. Tampé,et al. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] Tatiana A. Tatusova,et al. NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..
[23] J. Bluestone,et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. , 2004, Immunity.
[24] Mark Peakman,et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. , 2004, The Journal of clinical investigation.
[25] Peter M. Jones,et al. The development of new density gradient media for purifying human islets and islet-quality assessments. , 2004, Transplantation.
[26] M. Hotopf,et al. Cellular Immune Activation in Gulf War Veterans , 2004, Journal of Clinical Immunology.
[27] J. J. Rood,et al. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance , 2004, Immunogenetics.
[28] M. V. von Herrath,et al. Among CXCR3 Chemokines, IFN-γ-Inducible Protein of 10 kDa (CXC Chemokine Ligand (CXCL) 10) but Not Monokine Induced by IFN-γ (CXCL9) Imprints a Pattern for the Subsequent Development of Autoimmune Disease 1 , 2003, The Journal of Immunology.
[29] C. Panagiotopoulos,et al. Identification of a β-Cell-Specific HLA Class I Restricted Epitope in Type 1 Diabetes , 2003 .
[30] S. Endres,et al. Mature Dendritic Cells Derived from Human Monocytes Within 48 Hours: A Novel Strategy for Dendritic Cell Differentiation from Blood Precursors1 , 2003, The Journal of Immunology.
[31] C. Panagiotopoulos,et al. Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes. , 2003, Diabetes.
[32] K. Elsegood,et al. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes , 2003, Diabetes/metabolism research and reviews.
[33] N. Sarvetnick,et al. CCR4-bearing T cells participate in autoimmune diabetes. , 2002, The Journal of clinical investigation.
[34] M. Kaplan,et al. Comprehensive mapping of HLA‐A*0201–restricted CD8 T‐cell epitopes on PDC‐E2 in primary biliary cirrhosis , 2002, Hepatology.
[35] D. Serreze,et al. Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[36] F. Wong,et al. Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. , 2002, Immunity.
[37] N. Heaton,et al. Amelioration of streptozotocin-induced diabetes in mice using human islet cells derived from long-term culture in vitro1 , 2002, Transplantation.
[38] B. Boehm,et al. Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity. , 2002, Journal of autoimmunity.
[39] T. Wölfel,et al. The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays. , 2002, Journal of immunological methods.
[40] J. Shabanowitz,et al. The HA-2 Minor Histocompatibility Antigen Is Derived from a Diallelic Gene Encoding a Novel Human Class I Myosin Protein , 2001, The Journal of Immunology.
[41] P M Kloetzel,et al. Abrogation of CTL Epitope Processing by Single Amino Acid Substitution Flanking the C-Terminal Proteasome Cleavage Site1 , 2000, The Journal of Immunology.
[42] D. N. Perkins,et al. Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.
[43] A. Tomlinson,et al. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. , 1999, The Journal of clinical investigation.
[44] Anders Krogh,et al. Prediction of Signal Peptides and Signal Anchors by a Hidden Markov Model , 1998, ISMB.
[45] J. Yewdell,et al. Two Novel Routes of Transporter Associated with Antigen Processing (TAP)-independent Major Histocompatibility Complex Class I Antigen Processing , 1997, The Journal of experimental medicine.
[46] E. Leiter,et al. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. , 1997, Journal of immunology.
[47] C. Lindqvist,et al. Time-resolved fluorometric assay for natural killer activity using target cells labelled with a fluorescence enhancing ligand. , 1996, Journal of immunological methods.
[48] P. Kloetzel,et al. The cleavage preference of the proteasome governs the yield of antigenic peptides , 1995, The Journal of experimental medicine.
[49] D. Valmori,et al. Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum. , 1995, Journal of immunology.
[50] A. Ariza,et al. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. , 1994, Journal of immunology.
[51] K. Yamagata,et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. , 1993, The Journal of clinical investigation.
[52] M. Lotze,et al. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. , 1993, Journal of immunology.
[53] G. Eisenbarth,et al. Insulin prophylaxis in individuals at high risk of type 1 diabetes , 1993, The Lancet.
[54] O. Simell,et al. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.
[55] Maria L. Wei,et al. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides , 1992, Nature.
[56] C. Greenbaum,et al. Intra-islet insulin permits glucose to directly suppress pancreatic A cell function. , 1991, The Journal of clinical investigation.
[57] N. Simpson,et al. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.
[58] D. R. Gamble,et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. , 1985, The New England journal of medicine.
[59] R. Doolittle,et al. A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.
[60] G. Grodsky,et al. Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. , 1974, The Journal of clinical investigation.